Remove about
article thumbnail

FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors

Hall Render

Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014. On August 15, 2023, the U.S.

article thumbnail

Why We Should Care About the Move from Saliva to Living Cells in Precision Medicine

Bill of Health

With cell-based and other regenerative therapies entering the market (making up an entire FDA subgroup ), it well worth considering how cell-based medicine can advance the world of personalized consumer testing. A “yourtissueandyou” would be decidedly more informative — but also more invasive — than a 23andMe.

FDA 277
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI’s Ability to Manipulate Decision Making Requires a Moratorium on Its Use in Obtaining Consent for Biomedical Research

Bill of Health

Bard Until more is known about how to mitigate the threat of AI-fueled persuasion in human subject research, a ban on its use is the only reasonable way to keep the promise that we, as a country, made to those harmed while participating in research. By Jennifer S. These warnings echo those of the U.S.

article thumbnail

Reflections on Procedural Barriers to Pediatric COVID Vaccine Access

Bill of Health

Food and Drug Administration (FDA), many parents felt a glimmer of hope after a long time. For example, the group organized a physician coalition letter where several hundred doctors called on the FDA to urgently cut the bureaucratic tape and make vaccines accessible to young children. Solutions for the Future.

COVID-19 343
article thumbnail

Could Self-Operated Assisted Suicide Devices Be Coming to a Town near You?

Bill of Health

FDA Approval. Food and Drug Administration (FDA), which “ regulates the sale of medical device products (including diagnostic tests) in the U.S. ” Although it is questionable whether the FDA would ever approve the Sarco machine as a medical device, it turns out the FDA may not need to. .”

FDA 245
article thumbnail

How to Mitigate Ethical Challenges of AI-Driven Healthcare

Healthcare IT Today

The use of AI is revolutionizing the delivery of healthcare, but its use comes with significant ethical challenges that cannot be ignored, the most important of which involve bias and informed consent. . Another major ethical concern of AI use surrounds the principle of informed consent. About Natalie C.

article thumbnail

We May Not ‘Own’ Our Bodies. Should We?

Bill of Health

There’s a great value to be found in, say, shifting the conversation to informed consent regimes to address the transaction at the center of tissue provision in the first place. To be clear, I tend to agree that in this classification paradigm, it seems more trouble than it’s worth to go after ownership exclusively in human tissue.